DILOR Drug Patent Profile
✉ Email this page to a colleague
When do Dilor patents expire, and when can generic versions of Dilor launch?
Dilor is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in DILOR is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILOR?
- What are the global sales for DILOR?
- What is Average Wholesale Price for DILOR?
Summary for DILOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 3,310 |
| DailyMed Link: | DILOR at DailyMed |
US Patents and Regulatory Information for DILOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | DILOR | dyphylline | TABLET;ORAL | 084514-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Savage Labs | DILOR-400 | dyphylline | TABLET;ORAL | 084751-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
